Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Chung Ko

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Experimental Cell Research|June 24, 2004
Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxiaJen-Chung Ko, Yi-Ting Wang, Jia-Ling Yang
Thorax|November 18, 2016
Cementing an unwanted relationshipChia-Hao Chang, Li-Ta Keng, Jen-Chung Ko
Experimental Cell Research|April 2, 2008
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancerJen-Chung Ko, Jhao-Hao Hong, Lyu-Han Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutationsSheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2017
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative studyYu-Chien Liao, Wei-Yu Liao, Jia-Ling Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 3, 2020
Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic reviewMeng-Rui Lee, Lih-Yu Chang, Jen-Chung Ko, et al.
Oncotarget|May 29, 2018
Prognostic factors of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma: a real-world, large cohort studySheng-Kai Liang, Meng-Rui Lee, Wei-Yu Liao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 3, 2019
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort studyMeng-Rui Lee, Chih-Hsin Lee, Jann-Yuan Wang, et al.
Toxicology and Applied Pharmacology|August 4, 2011
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cellsJen-Chung Ko, Min-Shao Tsai, Shao-Hsing Weng, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2011
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cellsJen-Chung Ko, Min-Shao Tsai, Yu-Fan Chiu, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Experimental Cell Research|June 24, 2004
Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxiaJen-Chung Ko, Yi-Ting Wang, Jia-Ling Yang
Thorax|November 18, 2016
Cementing an unwanted relationshipChia-Hao Chang, Li-Ta Keng, Jen-Chung Ko
Experimental Cell Research|April 2, 2008
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancerJen-Chung Ko, Jhao-Hao Hong, Lyu-Han Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutationsSheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2017
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative studyYu-Chien Liao, Wei-Yu Liao, Jia-Ling Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 3, 2020
Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic reviewMeng-Rui Lee, Lih-Yu Chang, Jen-Chung Ko, et al.
Oncotarget|May 29, 2018
Prognostic factors of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma: a real-world, large cohort studySheng-Kai Liang, Meng-Rui Lee, Wei-Yu Liao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 3, 2019
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort studyMeng-Rui Lee, Chih-Hsin Lee, Jann-Yuan Wang, et al.
Toxicology and Applied Pharmacology|August 4, 2011
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cellsJen-Chung Ko, Min-Shao Tsai, Shao-Hsing Weng, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2011
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cellsJen-Chung Ko, Min-Shao Tsai, Yu-Fan Chiu, et al.
Pageof 6